University of Cambridge > Talks.cam > Seminars on Quantitative Biology @ CRUK Cambridge Institute  > Quantitative Biology Seminar

Quantitative Biology Seminar

Add to your list(s) Download to your calendar using vCal

If you have a question about this talk, please contact .

Many cancers are driven by hyperactive point mutants, most of which remain undruggable by the conventional approach with small molecule drugs. I will discuss biologics-based strategies to effectively target mutated cancer drivers, including the development of biologics that are exquisitely selective to cancer driver mutants and the use of covalent inhibitors to create actionable neoantigens for immune therapy.

This talk is part of the Seminars on Quantitative Biology @ CRUK Cambridge Institute series.

Tell a friend about this talk:

This talk is included in these lists:

Note that ex-directory lists are not shown.

 

© 2006-2025 Talks.cam, University of Cambridge. Contact Us | Help and Documentation | Privacy and Publicity